ACTB and acute respiratory distress syndrome: Through the analysis of the interaction between PPI proteins of anti-ALI therapeutic targets of eriodictyol, we found that eriodictyol may play an anti-ALI therapeutic role through core targets such as ALB, ACTB, AKT1, and VEGFA.